基本信息
views: 133
Career Trajectory
Bio
主要研究方向为靶向抗肿瘤和治疗地中海贫血祛铁创新药物研究,已发现针对非小细胞肺癌耐药的候选化合物SPH1188,并转让至上海医药集团股份有限公司进行临床前研究,2016年11月29日作为1.1类创新药获国家食品药品监督管理总局颁发“药物临床试验批件”,获准进入I-III期临床试验。发现具有自主知识产权的地中海贫血祛铁候选化合物CN128,有望解决我国在临床治疗地中海贫血方面药物匮乏的问题,2017年5月26日该候选化合物作为1.1类创新药获国家食品药品监督管理总局颁发“药物临床试验批件”,获准进入I-III期临床试验。
Research Interests
Papers共 228 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European journal of medicinal chemistry (2024): 115933-115933
Haiyang Wang,Yihui Zhou, Li Lu,Jie Cen, Zhenying Wu,Bo Yang,Chengliang Zhu,Ji Cao,Yongping Yu,Wenteng Chen
ACS MEDICINAL CHEMISTRY LETTERS (2024)
Lei Zhang,Di Ke,Yuting Li,Hui Zhang,Xi Zhang,Sihan Wang, Shaokai Ni,Bo Peng, Huixuan Zeng,Tingjun Hou,Yushen Du,Peichen Pan,Yongping Yu,Wenteng Chen
European Journal of Medicinal Chemistry (2024): 116639
Liang Tao,Xinquan Yang,Chaodong Ge, Peng Zhang, Wenjian He, Xingbo Xu, Xin Li,Wenteng Chen,Yingying Yu,Huai Zhang,Sui-Dan Chen,Xiao-Yan Pan, Yunxing Su,Chengfu Xu,Yongping Yu,Ming-Hua Zheng,Junxia Min,Fudi Wang
Cell Metabolism (2024)
ORGANIC CHEMISTRY FRONTIERSno. 2 (2024): 422-426
Organic chemistry frontiersno. 13 (2023): 3269-3274
Load More
Author Statistics
#Papers: 228
#Citation: 4215
H-Index: 34
G-Index: 51
Sociability: 6
Diversity: 3
Activity: 32
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn